PGDx looks to raise $3.5M following FDA clearance for cancer detection tech
May 27, 2020 at 14:45 PM EDT
Canton-based biotechnology firm PGDx plans to use the funding to accelerate commercialization efforts for its cancer diagnostic test, which was recently cleared by the FDA.
